KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.000001 $0.000001 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $0.000001 $0.000001
52 weeks $0.000001 $0.0850

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
Jun 07, 2019 $0.0520 $0.0590 $0.0520 $0.0590 1 814
Jun 06, 2019 $0.0595 $0.0623 $0.0530 $0.0581 266 556
Jun 05, 2019 $0.0585 $0.0640 $0.0568 $0.0640 99 443
Jun 04, 2019 $0.0470 $0.0585 $0.0470 $0.0568 40 659
Jun 03, 2019 $0.0508 $0.0585 $0.0508 $0.0585 7 815
May 31, 2019 $0.0505 $0.0605 $0.0505 $0.0584 11 740
May 30, 2019 $0.0505 $0.0609 $0.0490 $0.0609 46 002
May 29, 2019 $0.0590 $0.0617 $0.0502 $0.0599 47 965
May 28, 2019 $0.0566 $0.0736 $0.0500 $0.0599 185 280
May 24, 2019 $0.0745 $0.0745 $0.0555 $0.0700 24 404
May 23, 2019 $0.0588 $0.0850 $0.0570 $0.0705 139 976
May 22, 2019 $0.0704 $0.0725 $0.0601 $0.0716 25 676
May 21, 2019 $0.0603 $0.0855 $0.0555 $0.0757 59 786
May 20, 2019 $0.0650 $0.0877 $0.0600 $0.0691 31 112
May 17, 2019 $0.0778 $0.0830 $0.0606 $0.0830 145 814
May 16, 2019 $0.0734 $0.0790 $0.0561 $0.0775 12 533
May 15, 2019 $0.0725 $0.0850 $0.0575 $0.0600 561 422
May 14, 2019 $0.0801 $0.0850 $0.0751 $0.0850 8 941
May 13, 2019 $0.0895 $0.0950 $0.0750 $0.0849 39 848
May 10, 2019 $0.0760 $0.0950 $0.0760 $0.0935 6 724
May 09, 2019 $0.0775 $0.0950 $0.0755 $0.0950 2 615
May 08, 2019 $0.0766 $0.0870 $0.0755 $0.0870 2 898
May 07, 2019 $0.0727 $0.0950 $0.0727 $0.0870 132 352
May 06, 2019 $0.0850 $0.0850 $0.0753 $0.0843 15 092
May 03, 2019 $0.0777 $0.0855 $0.0752 $0.0800 104 741
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT